Controversies in the Pharmacological Treatment of Uveitis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 32, 2015-10 ,pp. : 4682-4687

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema

By Yilmaz Taygan   Cordero-Coma Miguel   Federici Thomas J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 10, 2011-10 ,pp. : 1327-1335

Informa Healthcare

Access to resources Recommend Favorite

Pegaptanib octasodium for the treatment of diabetic macular edema

By Schartman Jerome P   Coney Joseph M   Hornik Joan H   Miller David G  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1317-1323

Informa Healthcare

Access to resources Recommend Favorite

Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration

By Comer Grant M   Ciulla Thomas A   Heier Jeffery S   Criswell Mark H  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 119-135

Informa Healthcare

Access to resources Recommend Favorite

Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant

By Ciulla Thomas A   Harris Alon   McIntyre Nathaniel   Jonescu-Cuypers Christian  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 953-959

Informa Healthcare

Access to resources Recommend Favorite